In-vitro stem cell derived red blood cells for transfusion: Are we there yet?

Yonsei Medical Journal

Volumn 55, Issue 2, 2014, Pages 304-309

  Kim, Hyun Ok ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

CD34+ cell; Erythroid culture; In vitro RBC production

Indexed keywords

CD34+ CELL; ERYTHROID CULTURE; IN VITRO RBC PRODUCTION;

ANTIGENS, CD34; BLOOD TRANSFUSION; CELL CULTURE TECHNIQUES; ERYTHROCYTES; ERYTHROPOIESIS; FETAL BLOOD; HUMANS; STEM CELLS;

EID: 84894228262     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2014.55.2.304     Document Type: Review

References (33)

1. Giangrande PLF. The history of blood transfusion. Br J Haematol 2000;110:758-67.
2. Yamamoto F, Marken J, Tsuji T, White T, Clausen H, Hakomori S. Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc alpha 1-2Gal alpha 1-3GalNAc transferase (histo-blood group A transferase) mRNA. J Biol Chem 1990; 265:1146-51.
3. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion 2010;50:584-8.
4. Seifried E, Klueter H, Weidmann C, Staudenmaier T, Schrezenmeier H, Henschler R, et al. How much blood is needed? Vox Sang 2011;100:10-21.
5. Buemi M, Lacquaniti A, Bolignano D, Cernaro V, Campo S, Grasso G, et al. Down with the erythropoietin. Long live the erythropoietin! Curr Drug Targets 2009;10:1028-32.
6. Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002;20:467-72.
7. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005; 23:69-74.
8. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006;24: 1255-6.
9. Baek EJ, Kim HS, Kim S, Jin H, Choi TY, Kim HO. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion 2008;48:2235-45.
10. Baek EJ, Kim HS, Kim JH, Kim NJ, Kim HO. Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer. Transfusion 2009;49: 2285-95.
11. Baek EJ, You J, Kim MS, Lee SY, Cho SJ, Kim E, et al. Enhanced production of red blood cells in suspension by electrostatic interactions with culture plates. Tissue Eng Part C Methods 2010;16: 1325-34.
12. Kim HO, Baek EJ. Red blood cell engineering in stroma and serum/plasma-free conditions and long term storage. Tissue Eng Part A 2012;18:117-26.
13. Koury MJ, Lichtman MA. Structure of the marrow and the hematopoietic microenvironment. In: Kaushansky K, Williams WJ, editors. Williams hematology. 8th ed. New York: McGraw-Hill Medical; 2010. p.41-73.
14. Tsiftsoglou AS, Vizirianakis IS, Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 2009;61:800-30.
15. Boehm D, Murphy WG, Al-Rubeai M. The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J Biotechnol 2009;144:127-34.
16. Giarratana MC, Rouard H, Dumont A, Kiger L, Safeukui I, Le Pennec PY, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011;118:5071-9.
17. Douay L, Giarratana MC. Ex vivo generation of human red blood cells: a new advance in stem cell engineering. Methods Mol Biol 2009;482:127-40.
18. Mountford J, Olivier E, Turner M. Prospects for the manufacture of red cells for transfusion. Br J Haematol 2010;149:22-34.
19. Nakamura Y. In vitro production of transfusable red blood cells. Biotechnol Genet Eng Rev 2008;25:187-201.
20. Choi HS, Lee EM, Kim HO, Park MI, Baek EJ. Autonomous control of terminal erythropoiesis via physical interactions among erythroid cells. Stem Cell Res 2013;10:442-53.
21. Park KS, Ahn J, Kim JY, Park H, Kim HO, Lee SH. Poly-l-lysine increases the ex vivo expansion and erythroid differentiation of human hematopoietic stem cells, as well as erythroid enucleation efficacy. Tissue Eng Part A 2014 Jan 24. [Epub ahead of print]
22. Defense Advanced Research Projects Agency. Defense Sciences Office. Available at: http://www.darpa.mil/Our_Work/DSO/Programs/Blood_Pharming.aspx.
23. DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR. Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol 2012;40:300-11.
24. Timmins NE, Nielsen LK. Blood cell manufacture: current methods and future challenges. Trends Biotechnol 2009;27:415-22.
25. Keller G, Kennedy M, Papayannopoulou T, Wiles MV. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 1993;13:473-86.
26. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
27. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2001;98:10716-21.
28. Ma F, Ebihara Y, Umeda K, Sakai H, Hanada S, Zhang H, et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A 2008;105:13087-92.
29. Mountford JC, Olivier E, Jordanides NE, de Sousa P, Turner ML. Red blood cells from pluripotent stem cells for use in transfusion. Regen Med 2010;5:411-23.
30. Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008;112:4475-84.
31. Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica 2010;95:1651-9.
32. Peyrard T, Bardiaux L, Krause C, Kobari L, Lapillonne H, Andreu G, et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011;25:206-16.
33. Daley GQ. Stem cells: roadmap to the clinic. J Clin Invest 2010; 120:8-10.